Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global Typhoid Fever Vaccines Market Growth 2022-2028

  • LP 4768988
  • 92 Pages
  • January 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of Typhoid Fever Vaccines will have significant change from previous year. According to our (LP Information) latest study, the global Typhoid Fever Vaccines market size is USD million in 2022 from USD 206.8 million in 2021, with a change of % between 2021 and 2022. The global Typhoid Fever Vaccines market size will reach USD 330.9 million in 2028, growing at a CAGR of 7.0% over the analysis period.

The United States Typhoid Fever Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Typhoid Fever Vaccines market, reaching US$ million by the year 2028. As for the Europe Typhoid Fever Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Typhoid Fever Vaccines players cover Sanofi Pasteur, GlaxoSmithKline, Bharat Biotech, and PaxVax, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Typhoid Fever Vaccines market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

Live Attenuated Vaccine

Conjugate Vaccine

Capsular Polysaccharide Vaccines

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Government Institution

Private Sector

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Sanofi Pasteur

GlaxoSmithKline

Bharat Biotech

PaxVax

Biomed

Prokarium

China National Biotec Group

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Typhoid Fever Vaccines Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Typhoid Fever Vaccines by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Typhoid Fever Vaccines by Country/Region, 2017, 2022 & 2028

2.2 Typhoid Fever Vaccines Segment by Type

2.2.1 Live Attenuated Vaccine

2.2.2 Conjugate Vaccine

2.2.3 Capsular Polysaccharide Vaccines

2.2.4 Others

2.3 Typhoid Fever Vaccines Sales by Type

2.3.1 Global Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)

2.3.2 Global Typhoid Fever Vaccines Revenue and Market Share by Type (2017-2022)

2.3.3 Global Typhoid Fever Vaccines Sale Price by Type (2017-2022)

2.4 Typhoid Fever Vaccines Segment by Application

2.4.1 Government Institution

2.4.2 Private Sector

2.5 Typhoid Fever Vaccines Sales by Application

2.5.1 Global Typhoid Fever Vaccines Sale Market Share by Application (2017-2022)

2.5.2 Global Typhoid Fever Vaccines Revenue and Market Share by Application (2017-2022)

2.5.3 Global Typhoid Fever Vaccines Sale Price by Application (2017-2022)

3 Global Typhoid Fever Vaccines by Company

3.1 Global Typhoid Fever Vaccines Breakdown Data by Company

3.1.1 Global Typhoid Fever Vaccines Annual Sales by Company (2020-2022)

3.1.2 Global Typhoid Fever Vaccines Sales Market Share by Company (2020-2022)

3.2 Global Typhoid Fever Vaccines Annual Revenue by Company (2020-2022)

3.2.1 Global Typhoid Fever Vaccines Revenue by Company (2020-2022)

3.2.2 Global Typhoid Fever Vaccines Revenue Market Share by Company (2020-2022)

3.3 Global Typhoid Fever Vaccines Sale Price by Company

3.4 Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Typhoid Fever Vaccines Product Location Distribution

3.4.2 Players Typhoid Fever Vaccines Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Typhoid Fever Vaccines by Geographic Region

4.1 World Historic Typhoid Fever Vaccines Market Size by Geographic Region (2017-2022)

4.1.1 Global Typhoid Fever Vaccines Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Typhoid Fever Vaccines Annual Revenue by Geographic Region

4.2 World Historic Typhoid Fever Vaccines Market Size by Country/Region (2017-2022)

4.2.1 Global Typhoid Fever Vaccines Annual Sales by Country/Region (2017-2022)

4.2.2 Global Typhoid Fever Vaccines Annual Revenue by Country/Region

4.3 Americas Typhoid Fever Vaccines Sales Growth

4.4 APAC Typhoid Fever Vaccines Sales Growth

4.5 Europe Typhoid Fever Vaccines Sales Growth

4.6 Middle East & Africa Typhoid Fever Vaccines Sales Growth

5 Americas

5.1 Americas Typhoid Fever Vaccines Sales by Country

5.1.1 Americas Typhoid Fever Vaccines Sales by Country (2017-2022)

5.1.2 Americas Typhoid Fever Vaccines Revenue by Country (2017-2022)

5.2 Americas Typhoid Fever Vaccines Sales by Type

5.3 Americas Typhoid Fever Vaccines Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Typhoid Fever Vaccines Sales by Region

6.1.1 APAC Typhoid Fever Vaccines Sales by Region (2017-2022)

6.1.2 APAC Typhoid Fever Vaccines Revenue by Region (2017-2022)

6.2 APAC Typhoid Fever Vaccines Sales by Type

6.3 APAC Typhoid Fever Vaccines Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Typhoid Fever Vaccines by Country

7.1.1 Europe Typhoid Fever Vaccines Sales by Country (2017-2022)

7.1.2 Europe Typhoid Fever Vaccines Revenue by Country (2017-2022)

7.2 Europe Typhoid Fever Vaccines Sales by Type

7.3 Europe Typhoid Fever Vaccines Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Typhoid Fever Vaccines by Country

8.1.1 Middle East & Africa Typhoid Fever Vaccines Sales by Country (2017-2022)

8.1.2 Middle East & Africa Typhoid Fever Vaccines Revenue by Country (2017-2022)

8.2 Middle East & Africa Typhoid Fever Vaccines Sales by Type

8.3 Middle East & Africa Typhoid Fever Vaccines Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines

10.3 Manufacturing Process Analysis of Typhoid Fever Vaccines

10.4 Industry Chain Structure of Typhoid Fever Vaccines

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Typhoid Fever Vaccines Distributors

11.3 Typhoid Fever Vaccines Customer

12 World Forecast Review for Typhoid Fever Vaccines by Geographic Region

12.1 Global Typhoid Fever Vaccines Market Size Forecast by Region

12.1.1 Global Typhoid Fever Vaccines Forecast by Region (2023-2028)

12.1.2 Global Typhoid Fever Vaccines Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Typhoid Fever Vaccines Forecast by Type

12.7 Global Typhoid Fever Vaccines Forecast by Application

13 Key Players Analysis

13.1 Sanofi Pasteur

13.1.1 Sanofi Pasteur Company Information

13.1.2 Sanofi Pasteur Typhoid Fever Vaccines Product Offered

13.1.3 Sanofi Pasteur Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Pasteur Main Business Overview

13.1.5 Sanofi Pasteur Latest Developments

13.2 GlaxoSmithKline

13.2.1 GlaxoSmithKline Company Information

13.2.2 GlaxoSmithKline Typhoid Fever Vaccines Product Offered

13.2.3 GlaxoSmithKline Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GlaxoSmithKline Main Business Overview

13.2.5 GlaxoSmithKline Latest Developments

13.3 Bharat Biotech

13.3.1 Bharat Biotech Company Information

13.3.2 Bharat Biotech Typhoid Fever Vaccines Product Offered

13.3.3 Bharat Biotech Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bharat Biotech Main Business Overview

13.3.5 Bharat Biotech Latest Developments

13.4 PaxVax

13.4.1 PaxVax Company Information

13.4.2 PaxVax Typhoid Fever Vaccines Product Offered

13.4.3 PaxVax Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 PaxVax Main Business Overview

13.4.5 PaxVax Latest Developments

13.5 Biomed

13.5.1 Biomed Company Information

13.5.2 Biomed Typhoid Fever Vaccines Product Offered

13.5.3 Biomed Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Biomed Main Business Overview

13.5.5 Biomed Latest Developments

13.6 Prokarium

13.6.1 Prokarium Company Information

13.6.2 Prokarium Typhoid Fever Vaccines Product Offered

13.6.3 Prokarium Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Prokarium Main Business Overview

13.6.5 Prokarium Latest Developments

13.7 China National Biotec Group

13.7.1 China National Biotec Group Company Information

13.7.2 China National Biotec Group Typhoid Fever Vaccines Product Offered

13.7.3 China National Biotec Group Typhoid Fever Vaccines Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 China National Biotec Group Main Business Overview

13.7.5 China National Biotec Group Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. Typhoid Fever Vaccines Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Typhoid Fever Vaccines Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Live Attenuated Vaccine

Table 4. Major Players of Conjugate Vaccine

Table 5. Major Players of Capsular Polysaccharide Vaccines

Table 6. Major Players of Others

Table 7. Global Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 8. Global Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)

Table 9. Global Typhoid Fever Vaccines Revenue by Type (2017-2022) & ($ million)

Table 10. Global Typhoid Fever Vaccines Revenue Market Share by Type (2017-2022)

Table 11. Global Typhoid Fever Vaccines Sale Price by Type (2017-2022) & (USD/Dose)

Table 12. Global Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 13. Global Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)

Table 14. Global Typhoid Fever Vaccines Revenue by Application (2017-2022)

Table 15. Global Typhoid Fever Vaccines Revenue Market Share by Application (2017-2022)

Table 16. Global Typhoid Fever Vaccines Sale Price by Application (2017-2022) & (USD/Dose)

Table 17. Global Typhoid Fever Vaccines Sales by Company (2020-2022) & (K Doses)

Table 18. Global Typhoid Fever Vaccines Sales Market Share by Company (2020-2022)

Table 19. Global Typhoid Fever Vaccines Revenue by Company (2020-2022) ($ Millions)

Table 20. Global Typhoid Fever Vaccines Revenue Market Share by Company (2020-2022)

Table 21. Global Typhoid Fever Vaccines Sale Price by Company (2020-2022) & (USD/Dose)

Table 22. Key Manufacturers Typhoid Fever Vaccines Producing Area Distribution and Sales Area

Table 23. Players Typhoid Fever Vaccines Products Offered

Table 24. Typhoid Fever Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 25. New Products and Potential Entrants

Table 26. Mergers & Acquisitions, Expansion

Table 27. Global Typhoid Fever Vaccines Sales by Geographic Region (2017-2022) & (K Doses)

Table 28. Global Typhoid Fever Vaccines Sales Market Share Geographic Region (2017-2022)

Table 29. Global Typhoid Fever Vaccines Revenue by Geographic Region (2017-2022) & ($ millions)

Table 30. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region (2017-2022)

Table 31. Global Typhoid Fever Vaccines Sales by Country/Region (2017-2022) & (K Doses)

Table 32. Global Typhoid Fever Vaccines Sales Market Share by Country/Region (2017-2022)

Table 33. Global Typhoid Fever Vaccines Revenue by Country/Region (2017-2022) & ($ millions)

Table 34. Global Typhoid Fever Vaccines Revenue Market Share by Country/Region (2017-2022)

Table 35. Americas Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)

Table 36. Americas Typhoid Fever Vaccines Sales Market Share by Country (2017-2022)

Table 37. Americas Typhoid Fever Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 38. Americas Typhoid Fever Vaccines Revenue Market Share by Country (2017-2022)

Table 39. Americas Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 40. Americas Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)

Table 41. Americas Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 42. Americas Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)

Table 43. APAC Typhoid Fever Vaccines Sales by Region (2017-2022) & (K Doses)

Table 44. APAC Typhoid Fever Vaccines Sales Market Share by Region (2017-2022)

Table 45. APAC Typhoid Fever Vaccines Revenue by Region (2017-2022) & ($ Millions)

Table 46. APAC Typhoid Fever Vaccines Revenue Market Share by Region (2017-2022)

Table 47. APAC Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 48. APAC Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)

Table 49. APAC Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 50. APAC Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)

Table 51. Europe Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)

Table 52. Europe Typhoid Fever Vaccines Sales Market Share by Country (2017-2022)

Table 53. Europe Typhoid Fever Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 54. Europe Typhoid Fever Vaccines Revenue Market Share by Country (2017-2022)

Table 55. Europe Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 56. Europe Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)

Table 57. Europe Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 58. Europe Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)

Table 59. Middle East & Africa Typhoid Fever Vaccines Sales by Country (2017-2022) & (K Doses)

Table 60. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Country (2017-2022)

Table 61. Middle East & Africa Typhoid Fever Vaccines Revenue by Country (2017-2022) & ($ Millions)

Table 62. Middle East & Africa Typhoid Fever Vaccines Revenue Market Share by Country (2017-2022)

Table 63. Middle East & Africa Typhoid Fever Vaccines Sales by Type (2017-2022) & (K Doses)

Table 64. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Type (2017-2022)

Table 65. Middle East & Africa Typhoid Fever Vaccines Sales by Application (2017-2022) & (K Doses)

Table 66. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)

Table 67. Key Market Drivers & Growth Opportunities of Typhoid Fever Vaccines

Table 68. Key Market Challenges & Risks of Typhoid Fever Vaccines

Table 69. Key Industry Trends of Typhoid Fever Vaccines

Table 70. Typhoid Fever Vaccines Raw Material

Table 71. Key Suppliers of Raw Materials

Table 72. Typhoid Fever Vaccines Distributors List

Table 73. Typhoid Fever Vaccines Customer List

Table 74. Global Typhoid Fever Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 75. Global Typhoid Fever Vaccines Sales Market Forecast by Region

Table 76. Global Typhoid Fever Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 77. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Region (2023-2028)

Table 78. Americas Typhoid Fever Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 79. Americas Typhoid Fever Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 80. APAC Typhoid Fever Vaccines Sales Forecast by Region (2023-2028) & (K Doses)

Table 81. APAC Typhoid Fever Vaccines Revenue Forecast by Region (2023-2028) & ($ millions)

Table 82. Europe Typhoid Fever Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 83. Europe Typhoid Fever Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Middle East & Africa Typhoid Fever Vaccines Sales Forecast by Country (2023-2028) & (K Doses)

Table 85. Middle East & Africa Typhoid Fever Vaccines Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Global Typhoid Fever Vaccines Sales Forecast by Type (2023-2028) & (K Doses)

Table 87. Global Typhoid Fever Vaccines Sales Market Share Forecast by Type (2023-2028)

Table 88. Global Typhoid Fever Vaccines Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 89. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Type (2023-2028)

Table 90. Global Typhoid Fever Vaccines Sales Forecast by Application (2023-2028) & (K Doses)

Table 91. Global Typhoid Fever Vaccines Sales Market Share Forecast by Application (2023-2028)

Table 92. Global Typhoid Fever Vaccines Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 93. Global Typhoid Fever Vaccines Revenue Market Share Forecast by Application (2023-2028)

Table 94. Sanofi Pasteur Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 95. Sanofi Pasteur Typhoid Fever Vaccines Product Offered

Table 96. Sanofi Pasteur Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 97. Sanofi Pasteur Main Business

Table 98. Sanofi Pasteur Latest Developments

Table 99. GlaxoSmithKline Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 100. GlaxoSmithKline Typhoid Fever Vaccines Product Offered

Table 101. GlaxoSmithKline Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 102. GlaxoSmithKline Main Business

Table 103. GlaxoSmithKline Latest Developments

Table 104. Bharat Biotech Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 105. Bharat Biotech Typhoid Fever Vaccines Product Offered

Table 106. Bharat Biotech Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 107. Bharat Biotech Main Business

Table 108. Bharat Biotech Latest Developments

Table 109. PaxVax Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 110. PaxVax Typhoid Fever Vaccines Product Offered

Table 111. PaxVax Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 112. PaxVax Main Business

Table 113. PaxVax Latest Developments

Table 114. Biomed Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 115. Biomed Typhoid Fever Vaccines Product Offered

Table 116. Biomed Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 117. Biomed Main Business

Table 118. Biomed Latest Developments

Table 119. Prokarium Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 120. Prokarium Typhoid Fever Vaccines Product Offered

Table 121. Prokarium Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 122. Prokarium Main Business

Table 123. Prokarium Latest Developments

Table 124. China National Biotec Group Basic Information, Typhoid Fever Vaccines Manufacturing Base, Sales Area and Its Competitors

Table 125. China National Biotec Group Typhoid Fever Vaccines Product Offered

Table 126. China National Biotec Group Typhoid Fever Vaccines Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)

Table 127. China National Biotec Group Main Business

Table 128. China National Biotec Group Latest Developments

List of Figures

Figure 1. Picture of Typhoid Fever Vaccines

Figure 2. Typhoid Fever Vaccines Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Typhoid Fever Vaccines Sales Growth Rate 2017-2028 (K Doses)

Figure 7. Global Typhoid Fever Vaccines Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Typhoid Fever Vaccines Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Live Attenuated Vaccine

Figure 10. Product Picture of Conjugate Vaccine

Figure 11. Product Picture of Capsular Polysaccharide Vaccines

Figure 12. Product Picture of Others

Figure 13. Global Typhoid Fever Vaccines Sales Market Share by Type in 2021

Figure 14. Global Typhoid Fever Vaccines Revenue Market Share by Type (2017-2022)

Figure 15. Typhoid Fever Vaccines Consumed in Government Institution

Figure 16. Global Typhoid Fever Vaccines Market: Government Institution (2017-2022) & (K Doses)

Figure 17. Typhoid Fever Vaccines Consumed in Private Sector

Figure 18. Global Typhoid Fever Vaccines Market: Private Sector (2017-2022) & (K Doses)

Figure 19. Global Typhoid Fever Vaccines Sales Market Share by Application (2017-2022)

Figure 20. Global Typhoid Fever Vaccines Revenue Market Share by Application in 2021

Figure 21. Typhoid Fever Vaccines Revenue Market by Company in 2021 ($ Million)

Figure 22. Global Typhoid Fever Vaccines Revenue Market Share by Company in 2021

Figure 23. Global Typhoid Fever Vaccines Sales Market Share by Geographic Region (2017-2022)

Figure 24. Global Typhoid Fever Vaccines Revenue Market Share by Geographic Region in 2021

Figure 25. Global Typhoid Fever Vaccines Sales Market Share by Region (2017-2022)

Figure 26. Global Typhoid Fever Vaccines Revenue Market Share by Country/Region in 2021

Figure 27. Americas Typhoid Fever Vaccines Sales 2017-2022 (K Doses)

Figure 28. Americas Typhoid Fever Vaccines Revenue 2017-2022 ($ Millions)

Figure 29. APAC Typhoid Fever Vaccines Sales 2017-2022 (K Doses)

Figure 30. APAC Typhoid Fever Vaccines Revenue 2017-2022 ($ Millions)

Figure 31. Europe Typhoid Fever Vaccines Sales 2017-2022 (K Doses)

Figure 32. Europe Typhoid Fever Vaccines Revenue 2017-2022 ($ Millions)

Figure 33. Middle East & Africa Typhoid Fever Vaccines Sales 2017-2022 (K Doses)

Figure 34. Middle East & Africa Typhoid Fever Vaccines Revenue 2017-2022 ($ Millions)

Figure 35. Americas Typhoid Fever Vaccines Sales Market Share by Country in 2021

Figure 36. Americas Typhoid Fever Vaccines Revenue Market Share by Country in 2021

Figure 37. United States Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 38. Canada Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 39. Mexico Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 40. Brazil Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 41. APAC Typhoid Fever Vaccines Sales Market Share by Region in 2021

Figure 42. APAC Typhoid Fever Vaccines Revenue Market Share by Regions in 2021

Figure 43. China Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 44. Japan Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 45. South Korea Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 46. Southeast Asia Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 47. India Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 48. Australia Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 49. Europe Typhoid Fever Vaccines Sales Market Share by Country in 2021

Figure 50. Europe Typhoid Fever Vaccines Revenue Market Share by Country in 2021

Figure 51. Germany Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 52. France Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 53. UK Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 54. Italy Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 55. Russia Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 56. Middle East & Africa Typhoid Fever Vaccines Sales Market Share by Country in 2021

Figure 57. Middle East & Africa Typhoid Fever Vaccines Revenue Market Share by Country in 2021

Figure 58. Egypt Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 59. South Africa Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 60. Israel Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 61. Turkey Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 62. GCC Country Typhoid Fever Vaccines Revenue Growth 2017-2022 ($ Millions)

Figure 63. Manufacturing Cost Structure Analysis of Typhoid Fever Vaccines in 2021

Figure 64. Manufacturing Process Analysis of Typhoid Fever Vaccines

Figure 65. Industry Chain Structure of Typhoid Fever Vaccines

Figure 66. Channels of Distribution

Figure 67. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390